DK0459666T3 - Lægemidler mod impotens - Google Patents

Lægemidler mod impotens

Info

Publication number: DK0459666T3
Authority: DK; Denmark
Prior art keywords: impotence; medicines; relieving; male; erectile impotence
Prior art date: 1990-05-31

Application number

DK91304430.1T

Other languages

English (en)

Inventor

George Mclean Milne

Michael Grant Wyllie

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-05-31

Filing date

1991-05-17

Publication date

1994-12-05

1991-05-17 Application filed by Pfizer filed Critical Pfizer

1994-12-05 Application granted granted Critical

1994-12-05 Publication of DK0459666T3 publication Critical patent/DK0459666T3/da

Links

201000001881 impotence Diseases 0.000 title abstract 3
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
230000001856 erectile effect Effects 0.000 abstract 2
239000002253 acid Substances 0.000 abstract 1
HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 abstract 1
229960000528 amlodipine Drugs 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
RUZYUOTYCVRMRZ-UHFFFAOYSA-N doxazosin Chemical compound C1OC2=CC=CC=C2OC1C(=O)N(CC1)CCN1C1=NC(N)=C(C=C(C(OC)=C2)OC)C2=N1 RUZYUOTYCVRMRZ-UHFFFAOYSA-N 0.000 abstract 1
229960001389 doxazosin Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)
Medicinal Preparation (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Harvester Elements (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
Tone Control, Compression And Expansion, Limiting Amplitude (AREA)
Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
Saccharide Compounds (AREA)

DK91304430.1T 1990-05-31 1991-05-17 Lægemidler mod impotens DK0459666T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US53149490A	1990-05-31	1990-05-31

Publications (1)

Publication Number	Publication Date
DK0459666T3 true DK0459666T3 (da)	1994-12-05

Family

ID=24117862

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91304430.1T DK0459666T3 (da)	1990-05-31	1991-05-17	Lægemidler mod impotens

Country Status (15)

Country	Link
EP (1)	EP0459666B1 (da)
JP (1)	JP2522609B2 (da)
KR (1)	KR930010582B1 (da)
AT (1)	ATE113839T1 (da)
AU (1)	AU620282B2 (da)
CA (1)	CA2043440C (da)
DE (1)	DE69105040T2 (da)
DK (1)	DK0459666T3 (da)
HU (1)	HU208076B (da)
IE (1)	IE63837B1 (da)
IL (1)	IL98258A (da)
MY (1)	MY106528A (da)
NZ (1)	NZ238339A (da)
PT (1)	PT97785B (da)
ZA (1)	ZA914135B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4223800A1 (de) *	1992-07-20	1994-01-27	Cassella Farbwerke Mainkur Ag	Verwendung von 1.2.5-Oxadiazol-2-oxiden zur Behandlung erektiler Dysfunktionen
ES2146249T3 (es) *	1993-02-10	2000-08-01	Bmra Corp Bv	Composicion farmaceutica para tratar la impotencia que contiene un inhibidor alfa-1 y un inhibidor alfa-2.
US6143746A (en) *	1994-01-21	2000-11-07	Icos Corporation	Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
GB9514465D0 (en) *	1995-07-14	1995-09-13	Glaxo Lab Sa	Chemical compounds
CA2205384C (en) *	1994-11-16	2004-06-29	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
US6268369B1 (en)	1994-11-16	2001-07-31	Synaptic Pharmaceutical Corporation	5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
CZ278497A3 (cs) *	1995-03-14	1998-04-15	Vivus, Incorporated	Způsob a sestava zařízení k prevenci impotence
GB9514473D0 (en) *	1995-07-14	1995-09-13	Glaxo Lab Sa	Chemical compounds
GB9514464D0 (en) *	1995-07-14	1995-09-13	Glaxo Lab Sa	Medicaments
US6228861B1 (en)	1995-11-16	2001-05-08	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
ATE215950T1 (de)	1996-05-10	2002-04-15	Icos Corp	Carbolinderivate
US6245773B1 (en)	1996-05-16	2001-06-12	Synaptic Pharmaceutical Corporation	5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
US6172066B1 (en)	1996-05-16	2001-01-09	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
US6432401B2 (en) *	2000-05-12	2002-08-13	Novalar Pharmaceuticals, Inc.	Local anesthetic methods and kits
EP0849264A1 (de) *	1996-12-20	1998-06-24	HEUMANN PHARMA GmbH	Neue polymorphe Form von doxazosinmesylat (Form I)
DE59611417D1 (de) *	1996-12-20	2007-03-29	Heumann Pharma Gmbh & Co	Neue polymorphe Form von Doxazosinmesylat (Form III)
EP0849265A1 (de) *	1996-12-20	1998-06-24	HEUMANN PHARMA GmbH	Neue polymorphe Form von Doxazosin-Mesylat (Form II)
BR9813699A (pt) *	1997-12-16	2000-10-10	Pfizer Prod Inc	Combinação eficaz para o tratamento da impotência
DE19800214A1 (de)	1998-01-06	1999-07-15	Knoll Ag	Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür
US6268377B1 (en) *	1998-09-28	2001-07-31	Merck & Co., Inc.	Method for treating androgen-related conditions
RU2135195C1 (ru) *	1998-12-17	1999-08-27	Овсюк Валерий Григорьевич	Способ получения материала, содержащего клетки предстательной железы, материал, содержащий клетки предстательной железы, и способы лечения фиброматоза матки, хронического простатита и нарушений мужской половой функции методом трансплантации
US6680323B2 (en)	1998-12-23	2004-01-20	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
US6274585B1 (en)	1998-12-23	2001-08-14	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
GB0008332D0 (en) *	2000-04-04	2000-05-24	Pfizer Ltd	Treament
US6521647B2 (en)	2000-04-04	2003-02-18	Pfizer Inc.	Treatment of renal disorders
US6720324B2 (en)	2000-07-05	2004-04-13	Synaptic Pharmaceutical Corporation	Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4925837A (en) *	1984-09-14	1990-05-15	Synthelabo	Pharmaceutical compositions

1991
- 1991-05-17 DK DK91304430.1T patent/DK0459666T3/da active
- 1991-05-17 AT AT91304430T patent/ATE113839T1/de not_active IP Right Cessation
- 1991-05-17 EP EP91304430A patent/EP0459666B1/en not_active Expired - Lifetime
- 1991-05-17 DE DE69105040T patent/DE69105040T2/de not_active Expired - Fee Related
- 1991-05-24 IL IL9825891A patent/IL98258A/en not_active IP Right Cessation
- 1991-05-29 PT PT97785A patent/PT97785B/pt not_active IP Right Cessation
- 1991-05-29 CA CA002043440A patent/CA2043440C/en not_active Expired - Fee Related
- 1991-05-29 MY MYPI91000937A patent/MY106528A/en unknown
- 1991-05-30 ZA ZA914135A patent/ZA914135B/xx unknown
- 1991-05-30 IE IE184291A patent/IE63837B1/en not_active IP Right Cessation
- 1991-05-30 NZ NZ238339A patent/NZ238339A/en unknown
- 1991-05-30 KR KR1019910008934A patent/KR930010582B1/ko not_active Expired - Fee Related
- 1991-05-30 AU AU78077/91A patent/AU620282B2/en not_active Ceased
- 1991-05-30 HU HU911810A patent/HU208076B/hu not_active IP Right Cessation
- 1991-05-31 JP JP3129562A patent/JP2522609B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0459666A3 (en)	1992-06-03
IE63837B1 (en)	1995-06-14
PT97785A (pt)	1992-02-28
KR910019618A (ko)	1991-12-19
KR930010582B1 (ko)	1993-10-30
JP2522609B2 (ja)	1996-08-07
IE911842A1 (en)	1991-12-04
IL98258A0 (en)	1992-06-21
DE69105040T2 (de)	1995-03-23
CA2043440C (en)	1996-07-30
MY106528A (en)	1995-06-30
JPH04235917A (ja)	1992-08-25
HU911810D0 (en)	1991-12-30
AU7807791A (en)	1991-12-05
HUT58520A (en)	1992-03-30
IL98258A (en)	1996-01-31
EP0459666A2 (en)	1991-12-04
EP0459666B1 (en)	1994-11-09
PT97785B (pt)	1999-01-29
NZ238339A (en)	1997-07-27
HU208076B (en)	1993-08-30
ATE113839T1 (de)	1994-11-15
DE69105040D1 (de)	1994-12-15
CA2043440A1 (en)	1991-12-01
AU620282B2 (en)	1992-02-13
ZA914135B (en)	1993-01-27

Publication	Publication Date	Title
DE69105040D1 (de)	1994-12-15	Arzneimittel gegen Impotenz.
ATE145551T1 (de)	1996-12-15	Brausedosisform sowie verfahren zu deren verabreichung
DE58906926D1 (de)	1994-03-24	Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
ATE168268T1 (de)	1998-08-15	Behandlung von menschlichen retrovirus- infektionen mit 2',3'-dideoxyinosin
ATE211387T1 (de)	2002-01-15	Oral 1alpha-hydroxyprevitamin d
LU90856I2 (fr)	2002-01-24	Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables
ATE189400T1 (de)	2000-02-15	Knochenwachstumsfördernde zusammensetzung
TW273550B (da)	1996-04-01
NO922936D0 (no)	1992-07-23	Fremstilling av fettsyremedikamenter
PT615754E (pt)	2002-11-29	Formas solidas de administracao oral de libertacao controlada flupertina
EP0550006A3 (en)	1994-11-23	Use of n-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells
ES2026304A6 (es)	1992-04-16	Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
DK0458588T3 (da)	1995-03-13	Behandling af okulær hypertension med en synergistisk kombination til okulær administration
FI945510A0 (fi)	1994-11-23	Klavulaanihapon diamiinisuolat
EP0362847A3 (en)	1991-03-27	The use of etoperidone for preparing a pharmaceutical composition for treating male impotence
ES2108680T3 (es)	1998-01-01	Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
GR3007995T3 (da)	1993-08-31
IT9086204A0 (it)	1990-05-31	Metodo per la cura dell'impotenza erettiva maschile
FI943875L (fi)	1994-08-23	2,3,4,5-Tetrahydro-1H-3-bentsatsepiinejä ja niiden farmaseuttisesti hyväksyttäviä happoadditiosuoloja
IL98200A0 (en)	1992-06-21	Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
RU93044256A (ru)	1996-06-10	Способ лечения саркоидоза
EP0482919A3 (en)	1992-08-26	Method and composition for treating leg weakness in fowl by the administration of a non-steroidal anti-inflammatory drug
UA16000A1 (uk)	1997-08-29	Спосіб лікуваhhя гіпотрофії поросят
RU93042104A (ru)	1996-05-20	Противокашлевая композиция, содержащая декстрометорфан, способ ее применения